Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 179

1.

Effects of nicotinic acetylcholine receptor agonists on cognition in rhesus monkeys with a chronic cocaine self-administration history.

Gould RW, Garg PK, Garg S, Nader MA.

Neuropharmacology. 2013 Jan;64:479-88. doi: 10.1016/j.neuropharm.2012.08.004. Epub 2012 Aug 23.

2.

Effects of varenicline on the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys.

Gould RW, Czoty PW, Nader SH, Nader MA.

J Pharmacol Exp Ther. 2011 Nov;339(2):678-86. doi: 10.1124/jpet.111.185538. Epub 2011 Aug 19.

3.

Activation of α7 nicotinic receptors improves phencyclidine-induced deficits in cognitive tasks in rats: implications for therapy of cognitive dysfunction in schizophrenia.

McLean SL, Grayson B, Idris NF, Lesage AS, Pemberton DJ, Mackie C, Neill JC.

Eur Neuropsychopharmacol. 2011 Apr;21(4):333-43. doi: 10.1016/j.euroneuro.2010.06.003. Epub 2010 Jul 13.

PMID:
20630711
4.

Effects of chronic varenicline treatment on nicotine, cocaine, and concurrent nicotine+cocaine self-administration.

Mello NK, Fivel PA, Kohut SJ, Carroll FI.

Neuropsychopharmacology. 2014 Apr;39(5):1222-31. doi: 10.1038/npp.2013.325. Epub 2013 Nov 22.

5.

Effects of chronic cocaine self-administration on cognition and cerebral glucose utilization in Rhesus monkeys.

Gould RW, Gage HD, Nader MA.

Biol Psychiatry. 2012 Nov 15;72(10):856-63. doi: 10.1016/j.biopsych.2012.05.001. Epub 2012 Jun 5.

6.

Pharmacologic characterization of a nicotine-discriminative stimulus in rhesus monkeys.

Cunningham CS, Javors MA, McMahon LR.

J Pharmacol Exp Ther. 2012 Jun;341(3):840-9. doi: 10.1124/jpet.112.193078. Epub 2012 Mar 21.

7.

Effects of the nicotinic agonist varenicline on the performance of tasks of cognition in aged and middle-aged rhesus and pigtail monkeys.

Terry AV Jr, Plagenhoef M, Callahan PM.

Psychopharmacology (Berl). 2016 Mar;233(5):761-71. doi: 10.1007/s00213-015-4154-0. Epub 2015 Nov 27.

8.
9.

Activation of the alpha-7 nicotinic acetylcholine receptor (α7 nAchR) reverses referred mechanical hyperalgesia induced by colonic inflammation in mice.

Costa R, Motta EM, Manjavachi MN, Cola M, Calixto JB.

Neuropharmacology. 2012 Oct;63(5):798-805. doi: 10.1016/j.neuropharm.2012.06.004. Epub 2012 Jun 18.

PMID:
22722030
10.

The nicotinic α7 receptor agonist GTS-21 improves cognitive performance in ketamine impaired rhesus monkeys.

Cannon CE, Puri V, Vivian JA, Egbertson MS, Eddins D, Uslaner JM.

Neuropharmacology. 2013 Jan;64:191-6. doi: 10.1016/j.neuropharm.2012.05.003. Epub 2012 May 29.

PMID:
22659472
11.

The high-affinity nAChR partial agonists varenicline and sazetidine-A exhibit reinforcing properties in rats.

Paterson NE, Min W, Hackett A, Lowe D, Hanania T, Caldarone B, Ghavami A.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Dec 1;34(8):1455-64. doi: 10.1016/j.pnpbp.2010.07.037. Epub 2010 Aug 11.

PMID:
20708056
12.

Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder.

Hong LE, Thaker GK, McMahon RP, Summerfelt A, Rachbeisel J, Fuller RL, Wonodi I, Buchanan RW, Myers C, Heishman SJ, Yang J, Nye A.

Arch Gen Psychiatry. 2011 Dec;68(12):1195-206. doi: 10.1001/archgenpsychiatry.2011.83. Epub 2011 Aug 1.

13.

The potential of nicotinic enhancement of cognitive remediation training in schizophrenia.

Hahn B, Gold JM, Buchanan RW.

Neuropharmacology. 2013 Jan;64:185-90. doi: 10.1016/j.neuropharm.2012.05.050. Epub 2012 Jun 13.

PMID:
22705396
14.

Subtype-selective nicotinic acetylcholine receptor agonists can improve cognitive flexibility in an attentional set shifting task.

Wood C, Kohli S, Malcolm E, Allison C, Shoaib M.

Neuropharmacology. 2016 Jun;105:106-113. doi: 10.1016/j.neuropharm.2016.01.006. Epub 2016 Jan 6.

PMID:
26772970
15.

Nicotine improves performance in an attentional set shifting task in rats.

Allison C, Shoaib M.

Neuropharmacology. 2013 Jan;64:314-20. doi: 10.1016/j.neuropharm.2012.06.055. Epub 2012 Jul 6.

PMID:
22776507
16.
17.

Selective α4β2 nicotinic acetylcholine receptor agonists target epigenetic mechanisms in cortical GABAergic neurons.

Maloku E, Kadriu B, Zhubi A, Dong E, Pibiri F, Satta R, Guidotti A.

Neuropsychopharmacology. 2011 Jun;36(7):1366-74. doi: 10.1038/npp.2011.21. Epub 2011 Mar 2.

18.

Chronic cocaine self-administration in rhesus monkeys: impact on associative learning, cognitive control, and working memory.

Porter JN, Olsen AS, Gurnsey K, Dugan BP, Jedema HP, Bradberry CW.

J Neurosci. 2011 Mar 30;31(13):4926-34. doi: 10.1523/JNEUROSCI.5426-10.2011.

19.

Effects of prior cocaine self-administration on cognitive performance in female cynomolgus monkeys.

Kromrey SA, Gould RW, Nader MA, Czoty PW.

Psychopharmacology (Berl). 2015 Jun;232(11):2007-16. doi: 10.1007/s00213-015-3865-6. Epub 2015 Jan 31.

20.

Chronic sazetidine-A at behaviorally active doses does not increase nicotinic cholinergic receptors in rodent brain.

Hussmann GP, Turner JR, Lomazzo E, Venkatesh R, Cousins V, Xiao Y, Yasuda RP, Wolfe BB, Perry DC, Rezvani AH, Levin ED, Blendy JA, Kellar KJ.

J Pharmacol Exp Ther. 2012 Nov;343(2):441-50. doi: 10.1124/jpet.112.198085. Epub 2012 Aug 16.

Supplemental Content

Support Center